^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

quemliclustat (AB680)

i
Associations
Company:
Arcus Biosci, Gilead, Otsuka, Takeda
Drug class:
CD73 inhibitor
Associations
Phase 2
Arcus Biosciences, Inc.
Recruiting
Last update posted :
06/05/2024
Initiation :
06/10/2022
Primary completion :
09/01/2026
Completion :
06/01/2027
PD-L1
|
PD-L1 expression
|
5-fluorouracil • oxaliplatin • Yutuo (zimberelimab) • leucovorin calcium • domvanalimab (AB154) • quemliclustat (AB680)